Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert B Jenkins

Showing results (61-70 of 269) with videos related to

Pageof 27
Sort By:
Nanomedicine : Nanotechnology, Biology, and Medicine|October 10, 2018
Cationic carrier peptide enhances cerebrovascular targeting of nanoparticles in Alzheimer's disease brainKristen M Ahlschwede, Geoffry L Curran, Jens T Rosenberg, et al.
Brain Pathology (Zurich, Switzerland)|August 20, 2008
Interphase cytogenetics for 1p19q and t(1;19)(q10;p10) may distinguish prognostically relevant subgroups in extraventricular neurocytomaFausto J Rodriguez, Renan A Mota, Bernd W Scheithauer, et al.
American Journal of Clinical Pathology|January 29, 2013
Comparison of fluorescence in situ hybridization (FISH) and dual-ISH (DISH) in the determination of HER2 status in breast cancerAaron S Mansfield, William R Sukov, Jeanette E Eckel-Passow, et al.
The American Journal of Surgical Pathology|March 19, 2008
Ependymal tumors with sarcomatous change ("ependymosarcoma"): a clinicopathologic and molecular cytogenetic studyFausto J Rodriguez, Bernd W Scheithauer, Arie Perry, et al.
Neuro-Oncology|May 28, 2015
Telomere maintenance and the etiology of adult gliomaKyle M Walsh, John K Wiencke, Daniel H Lachance, et al.
BMC Urology|October 30, 2020
8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressivenessJeanette E Eckel-Passow, Huihuang Yan, Matthew L Kosel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2017
IGF1R Protein Expression Is Not Associated with Differential Benefit to Concurrent Trastuzumab in Early-Stage HER2<sup>+</sup> Breast Cancer from the North Central Cancer Treatment Group (Alliance) Adjuvant Trastuzumab Trial N9831Monica M Reinholz, Beiyun Chen, Amylou C Dueck, et al.
Investigational New Drugs|September 2, 2011
Phase I study of temsirolimus in combination with EKB-569 in patients with advanced solid tumorsAlan H Bryce, Ravi Rao, Jann Sarkaria, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 1, 2008
Salivary gland-type lung carcinomas: an EGFR immunohistochemical, molecular genetic, and mutational analysis studyRicardo S Macarenco, Timothy S Uphoff, Heather Flynn Gilmer, et al.
Cancer|October 24, 2013
HER-2/neu gene amplification in relation to expression of HER2 and HER3 proteins in patients with esophageal adenocarcinomaHarry H Yoon, William R Sukov, Qian Shi, et al.
Pageof 27

Showing results (61-70 of 269) with videos related to

Sort By:
Pageof 27
Nanomedicine : Nanotechnology, Biology, and Medicine|October 10, 2018
Cationic carrier peptide enhances cerebrovascular targeting of nanoparticles in Alzheimer's disease brainKristen M Ahlschwede, Geoffry L Curran, Jens T Rosenberg, et al.
Brain Pathology (Zurich, Switzerland)|August 20, 2008
Interphase cytogenetics for 1p19q and t(1;19)(q10;p10) may distinguish prognostically relevant subgroups in extraventricular neurocytomaFausto J Rodriguez, Renan A Mota, Bernd W Scheithauer, et al.
American Journal of Clinical Pathology|January 29, 2013
Comparison of fluorescence in situ hybridization (FISH) and dual-ISH (DISH) in the determination of HER2 status in breast cancerAaron S Mansfield, William R Sukov, Jeanette E Eckel-Passow, et al.
The American Journal of Surgical Pathology|March 19, 2008
Ependymal tumors with sarcomatous change ("ependymosarcoma"): a clinicopathologic and molecular cytogenetic studyFausto J Rodriguez, Bernd W Scheithauer, Arie Perry, et al.
Neuro-Oncology|May 28, 2015
Telomere maintenance and the etiology of adult gliomaKyle M Walsh, John K Wiencke, Daniel H Lachance, et al.
BMC Urology|October 30, 2020
8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressivenessJeanette E Eckel-Passow, Huihuang Yan, Matthew L Kosel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2017
IGF1R Protein Expression Is Not Associated with Differential Benefit to Concurrent Trastuzumab in Early-Stage HER2<sup>+</sup> Breast Cancer from the North Central Cancer Treatment Group (Alliance) Adjuvant Trastuzumab Trial N9831Monica M Reinholz, Beiyun Chen, Amylou C Dueck, et al.
Investigational New Drugs|September 2, 2011
Phase I study of temsirolimus in combination with EKB-569 in patients with advanced solid tumorsAlan H Bryce, Ravi Rao, Jann Sarkaria, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 1, 2008
Salivary gland-type lung carcinomas: an EGFR immunohistochemical, molecular genetic, and mutational analysis studyRicardo S Macarenco, Timothy S Uphoff, Heather Flynn Gilmer, et al.
Cancer|October 24, 2013
HER-2/neu gene amplification in relation to expression of HER2 and HER3 proteins in patients with esophageal adenocarcinomaHarry H Yoon, William R Sukov, Qian Shi, et al.
Pageof 27